Labena will once again take part in one of the world’s leading conferences in the field of biologics — PEGS Europe 2025, taking place from November 10–14 in Lisbon.

The PEGS (Protein & Antibody Engineering Summit) conference brings together global experts in the development, characterization, and production of biologics, including cutting-edge innovations in cell and gene therapy, analytical approaches, and process development.

The Labena team, operating as a Contract Research Organization (CRO) and partner for biologics development, will showcase our advanced analytical and development services covering the entire biologics development pathway — from early discovery to GMP analytics.

Our participation will highlight:

  • Advanced analytical approaches (incl. GMP analytics),
  • Process development and characterization for biologics, and
  • Comprehensive solutions supporting gene therapy development.

We look forward to connecting with existing and new partners and exchanging insights on the future of biotechnology and drug development.

If you are attending the conference — let’s meet in Lisbon!
📩 Contact us at enquiries@labena.si.